Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. Scope of the Report: This report focuses on the Phenylketonuria (PKU) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in 2016 is about 34.48% and the revenue proportion of medications is about 42.47%. Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 61.54%. North America is the largest consumption place, with a consumption market share nearly 57.18% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29.28%. The worldwide market for Phenylketonuria (PKU) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Biomarin Vitaflo Mead Johnson Nutricia Abbott Dr. Sch?r Prominmetabolics Cambrooke Juvela Firstplay Dietary Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Medications Supplements Others Market Segment by Applications, can be divided into Household Hospital Others There are 15 Chapters to deeply display the global Phenylketonuria (PKU) market. Chapter 1 to describe Phenylketonuria (PKU) Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Phenylketonuria (PKU), with sales, revenue, and price of Phenylketonuria (PKU), in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Phenylketonuria (PKU), for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Phenylketonuria (PKU) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Phenylketonuria (PKU) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Phenylketonuria (PKU) Introduction 1.2 Market Analysis by Type 1.2.1 Medications 1.2.2 Supplements 1.2.3 Others 1.3 Market Analysis by Applications 1.3.1 Household 1.3.2 Hospital 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexi
